These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 16436337)

  • 1. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
    El-Darouti MA; Marzouk SA; Azzam O; Fawzi MM; Abdel-Halim MR; Zayed AA; Leheta TM
    Eur J Dermatol; 2006; 16(1):17-22. PubMed ID: 16436337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
    Khopkar U; Doshi BR; Dongre AM; Gujral S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic profile of hypopigmented mycosis fungoides in India.
    Koorse S; Tirumalae R; Yeliur IK; Jayaseelan E
    Am J Dermatopathol; 2012 Apr; 34(2):161-4. PubMed ID: 22240772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory vitiligo-like macules that simulate hypopigmented mycosis fungoides.
    Petit T; Cribier B; Bagot M; Wechsler J
    Eur J Dermatol; 2003; 13(4):410-2. PubMed ID: 12948929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypopigmented mycosis fungoides versus mycosis fungoides with concomitant hypopigmented lesions: same disease or different variants of mycosis fungoides?
    Furlan FC; Pereira BA; Sotto MN; Sanches JA
    Dermatology; 2014; 229(3):271-4. PubMed ID: 25323446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets.
    Seif El Nasr H; Shaker OG; Fawzi MM; El-Hanafi G
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):103-8. PubMed ID: 22151832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of melanocytes in hypopigmented mycosis fungoides: a study of 18 patients.
    Furlan FC; de Paula Pereira BA; da Silva LF; Sanches JA
    J Cutan Pathol; 2014 Feb; 41(2):101-7. PubMed ID: 24219812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypopigmented Mycosis Fungoides Mimicking Vitiligo.
    Kim JC; Kim YC
    Am J Dermatopathol; 2021 Mar; 43(3):213-216. PubMed ID: 33156019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of repigmentation in two cases of hypopigmented type of vitiligo.
    Anbar TS; El-Sawy AE; Attia SK; Moftah NH; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):156-8. PubMed ID: 19438996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo.
    Singh ZN; Tretiakova MS; Shea CR; Petronic-Rosic VM
    Mod Pathol; 2006 Sep; 19(9):1255-60. PubMed ID: 16778827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annular hypopigmented mycosis fungoides: a novel ringed variant.
    Uhlenhake EE; Mehregan DM
    J Cutan Pathol; 2012 May; 39(5):535-9. PubMed ID: 22515225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides.
    Magro CM; Hagen JW; Crowson AN; Liu YC; Mihm M; Drucker NM; Yassin AH
    J Dermatol; 2014 Jul; 41(7):609-17. PubMed ID: 24806661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic features in vitiligo.
    Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
    Izban KF; Hsi ED; Alkan S
    Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological spectrum of mycosis fungoides type cutaneous T-cell lymphoma.
    Shaikh ZI; Rahman SB
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):171-4. PubMed ID: 16542594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic study of normal skin in cases of mycosis fungoides.
    El-Darouti MA; Marzouk SA; Bosseila M; Zeid OA; El-Safouri O; Zayed A; El-Ramly A; Abdel-Halim MR
    Int J Dermatol; 2006 Sep; 45(9):1043-6. PubMed ID: 16961506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycosis fungoides in children and adolescents: a report of six cases with predominantly hypopigmentation, along with a literature review].
    Rizzo FA; Vilar EG; Pantaleão L; Fonseca EC; Magrin PF; Henrique-Xavier M; Rochael MC
    Dermatol Online J; 2012 Mar; 18(3):5. PubMed ID: 22483516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus.
    Lai LG; Xu AE
    Skin Res Technol; 2011 Nov; 17(4):404-10. PubMed ID: 21429011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides associated with unusual epidermal hyperplasia.
    Puig L; Musulén E; Fernández-Figueras MT; Miralles J; Sitjas D; De Moragas JM
    Clin Exp Dermatol; 1996 Jan; 21(1):61-4. PubMed ID: 8689775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.